Interestingly, when appraised in a model of CD14+-derived M2 macrophages model, the 2LC1 capsules reduced C-MYC expression and increased the one of CD86 and HLA-DR, likely indicating a shift from the pro-tumoral M2c-TAMs-related phenotype to a more M1-associated phenotype, with enhanced anti-tumor properties. This evidence concerns the gene MYC and neoplasm.